ReviewBritish journal of pharmacology2012

GLP-1R and amylin agonism in metabolic disease: complementary mechanisms and future opportunities.

Jonathan D Roth et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.